BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

467 related articles for article (PubMed ID: 32397226)

  • 1. Innate Type 2 Responses to Respiratory Syncytial Virus Infection.
    Norlander AE; Peebles RS
    Viruses; 2020 May; 12(5):. PubMed ID: 32397226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alarmins and innate lymphoid cells 2 activation: A common pathogenetic link connecting respiratory syncytial virus bronchiolitis and later wheezing/asthma?
    Rossi GA; Ballarini S; Salvati P; Sacco O; Colin AA
    Pediatr Allergy Immunol; 2022 Jun; 33(6):e13803. PubMed ID: 35754131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Respiratory syncytial virus infection activates IL-13-producing group 2 innate lymphoid cells through thymic stromal lymphopoietin.
    Stier MT; Bloodworth MH; Toki S; Newcomb DC; Goleniewska K; Boyd KL; Quitalig M; Hotard AL; Moore ML; Hartert TV; Zhou B; McKenzie AN; Peebles RS
    J Allergy Clin Immunol; 2016 Sep; 138(3):814-824.e11. PubMed ID: 27156176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thymic stromal lymphopoietin is induced by respiratory syncytial virus-infected airway epithelial cells and promotes a type 2 response to infection.
    Lee HC; Headley MB; Loo YM; Berlin A; Gale M; Debley JS; Lukacs NW; Ziegler SF
    J Allergy Clin Immunol; 2012 Nov; 130(5):1187-1196.e5. PubMed ID: 22981788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Uric acid pathway activation during respiratory virus infection promotes Th2 immune response via innate cytokine production and ILC2 accumulation.
    Fonseca W; Malinczak CA; Schuler CF; Best SKK; Rasky AJ; Morris SB; Cui TX; Popova AP; Lukacs NW
    Mucosal Immunol; 2020 Jul; 13(4):691-701. PubMed ID: 32047272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated Levels of Type 2 Respiratory Innate Lymphoid Cells in Human Infants with Severe Respiratory Syncytial Virus Bronchiolitis.
    Vu LD; Siefker D; Jones TL; You D; Taylor R; DeVincenzo J; Cormier SA
    Am J Respir Crit Care Med; 2019 Dec; 200(11):1414-1423. PubMed ID: 31237777
    [No Abstract]   [Full Text] [Related]  

  • 7. The CD4 T cell response to respiratory syncytial virus infection.
    Christiaansen AF; Knudson CJ; Weiss KA; Varga SM
    Immunol Res; 2014 Aug; 59(1-3):109-17. PubMed ID: 24838148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TSLP-Driven Chromatin Remodeling and Trained Systemic Immunity after Neonatal Respiratory Viral Infection.
    Malinczak CA; Parolia A; Fonseca W; Morris S; Rasky AJ; Bawa P; Zhang Y; Mire MM; Ziegler SF; Ptaschinski C; Chinnaiyan AM; Lukacs NW
    J Immunol; 2021 Mar; 206(6):1315-1328. PubMed ID: 33514510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Respiratory syncytial virus (RSV) evades the human adaptive immune system by skewing the Th1/Th2 cytokine balance toward increased levels of Th2 cytokines and IgE, markers of allergy--a review.
    Becker Y
    Virus Genes; 2006 Oct; 33(2):235-52. PubMed ID: 16972040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neutralization of IL-33 modifies the type 2 and type 3 inflammatory signature of viral induced asthma exacerbation.
    Warren KJ; Poole JA; Sweeter JM; DeVasure JM; Dickinson JD; Peebles RS; Wyatt TA
    Respir Res; 2021 Jul; 22(1):206. PubMed ID: 34266437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determinants of host susceptibility to murine respiratory syncytial virus (RSV) disease identify a role for the innate immunity scavenger receptor MARCO gene in human infants.
    High M; Cho HY; Marzec J; Wiltshire T; Verhein KC; Caballero MT; Acosta PL; Ciencewicki J; McCaw ZR; Kobzik L; Miller-DeGraff L; Gladwell W; Peden DB; Serra ME; Shi M; Weinberg C; Suzuki O; Wang X; Bell DA; Polack FP; Kleeberger SR
    EBioMedicine; 2016 Sep; 11():73-84. PubMed ID: 27554839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Respiratory syncytial virus prevents the subsequent development of ovalbumin-induced allergic responses by inhibiting ILC2 via the IL-33/ST2 pathway.
    Wang D; Bai S; Cui Y; Zhao N; Qi F; Liu J; Zeng S; Xu L; Hu H; Liu B
    Immunotherapy; 2018 Sep; 10(12):1065-1076. PubMed ID: 30027786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Innate immune dysfunction is associated with enhanced disease severity in infants with severe respiratory syncytial virus bronchiolitis.
    Mella C; Suarez-Arrabal MC; Lopez S; Stephens J; Fernandez S; Hall MW; Ramilo O; Mejias A
    J Infect Dis; 2013 Feb; 207(4):564-73. PubMed ID: 23204162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunopathogenesis of respiratory syncytial virus bronchiolitis.
    Bennett BL; Garofalo RP; Cron SG; Hosakote YM; Atmar RL; Macias CG; Piedra PA
    J Infect Dis; 2007 May; 195(10):1532-40. PubMed ID: 17436234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Attenuation of respiratory syncytial virus-induced and RIG-I-dependent type I IFN responses in human neonates and very young children.
    Marr N; Wang TI; Kam SH; Hu YS; Sharma AA; Lam A; Markowski J; Solimano A; Lavoie PM; Turvey SE
    J Immunol; 2014 Feb; 192(3):948-57. PubMed ID: 24391215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sex-associated TSLP-induced immune alterations following early-life RSV infection leads to enhanced allergic disease.
    Malinczak CA; Fonseca W; Rasky AJ; Ptaschinski C; Morris S; Ziegler SF; Lukacs NW
    Mucosal Immunol; 2019 Jul; 12(4):969-979. PubMed ID: 31076663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased innate immune cytokine responses correlate with disease severity in children with respiratory syncytial virus and human rhinovirus bronchiolitis.
    García C; Soriano-Fallas A; Lozano J; Leos N; Gomez AM; Ramilo O; Mejias A
    Pediatr Infect Dis J; 2012 Jan; 31(1):86-9. PubMed ID: 21829141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Responsiveness to respiratory syncytial virus in neonates is mediated through thymic stromal lymphopoietin and OX40 ligand.
    Han J; Dakhama A; Jia Y; Wang M; Zeng W; Takeda K; Shiraishi Y; Okamoto M; Ziegler SF; Gelfand EW
    J Allergy Clin Immunol; 2012 Nov; 130(5):1175-1186.e9. PubMed ID: 23036746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impairment of T cell immunity by the respiratory syncytial virus: targeting virulence mechanisms for therapy and prophylaxis.
    González PA; Bueno SM; Riedel CA; Kalergis AM
    Curr Med Chem; 2009; 16(34):4609-25. PubMed ID: 19903147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perinatal lamb model of respiratory syncytial virus (RSV) infection.
    Derscheid RJ; Ackermann MR
    Viruses; 2012 Oct; 4(10):2359-78. PubMed ID: 23202468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.